Pluripotent bone marrow cells in leukemic mice elicit enhanced immune reactivity following Sheep Erythrocyte administration in-vivo. A possible S-LFA3 interactive immunotherapy

Journal of Experimental and Clinical Cancer Research

Volumn 22, Issue 2, 2003, Pages 213-221

  Law, S ^a   Begum, B ^a   Chaudhuri, S ^a  

^a CALCUTTA SCHOOL OF TROPICAL MEDICINE   (India)

Author keywords

Bone marrow compartmentalization; Immunotherapy; Pluripotent stem cells; Progenitor cells; Sheep leucocyte function antigen 3(S LFA3); Sheep red blood cells

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; ETHYLNITROSOUREA; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3; SHEEP LEUKOCYTE FUNCTION ANTIGEN 3; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CANCER IMMUNOTHERAPY; CELL DENSITY; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; CYTOTOXICITY; E ROSETTE; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; IMMUNOREACTIVITY; LEUKEMIA; MALE; MOUSE; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; SHEEP ERYTHROCYTE; STEM CELL; TUMOR IMMUNITY;

ANIMALS; ANTIGENS, CD34; BONE MARROW CELLS; CARCINOGENS; CELL MOVEMENT; CELL SEPARATION; ERYTHROCYTES; ETHYLNITROSOUREA; FEMALE; FLOW CYTOMETRY; IMMUNOTHERAPY; LEUKEMIA; MALE; MICE; PHAGOCYTOSIS; SHEEP; STEM CELLS; TIME FACTORS;

EID: 0038037953     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Auditore Hargreaves K., Krieger M., Jacobes C., Heimfeld S., Berenson R.J.: Human stem cell biology and therapy. In: Brenner M.K., Hoffbrand A.V. eds. Recent Advances in Haematology, Edinburgh, UK: Churchill Livingston, Vol. 8, 1996, 247-261.
2. Goss G., Szer J., Basser R.: Multiple cycles of aggressive chemotherapy prior to autologous peripheral stem cell - transplantation for lymphoma. Aust. Newz. J. Med. 27(3): 323-329, 1997.
3. Tannock I.F.: Conventional Cancer therapy: Promise broken or promise delayed. Lancet. 351(11): 9-16, 1998.
4. Bierman P.J., Bishop M.R. and Armitage J.O.: High dose chemotherapy with cellular support for Haematological Malignances. In: Morstyn G. and Sheridan W., eds. Cell Therapy. Cambridge: Cambridge University Press 1996: 337-351.
5. Sheridan W.: Cytokine only approaches to mobilization of progenitor cells. In: Morstyn G. and Sheridan W., eds. Cell Therapy. Cambridge: Cambridge University Press 1996: 146-182.
6. Welte K., Gabrilove J., Bronchud M.H., Platzer E. and Morstyn G.: Filgrastim (r-met-HuG-CSF): The First 10 years. Blood. 88 (6): 1907-1929, 1996.
7. Law S., Basu K., Banerjee S., Begum Bilquis, Das S.P. and Chaudhuri S.: Isolation and ex-vivo expansion of stem cells: physiological manipulation for cytotherapy. Ind. J. Physiol. and Allied Sci. 55(3): 114-122, 2001.
8. Testa N.G. and Dexter T.M.: Cytokines in Haemopoiesis: their application in oncology. In: Hickman J.A., Tritton T.A., eds. Cancer Chemotherapy. Oxford, London: Blackwell Scientific Publishers 1993: 344-347.
9. Archimbaud E., Michallet M., Philip I.: Granulocyte colony stimulating factor given in addition to Interferon-γ to mobilize peripheral blood stem cells for autologous transplantation in chronic myeloid leukaemia. Brit. J. Haematol. 99: 678-684, 1997.
10. Chaudhuri S. and Chaudhuri Swapna: An immunological approach to the role of sheep erythrocytes on the growth rate of ascitic fibrosarcoma in mice. Proc. 6th Int. Cong. Immunol., Toronto, Canada, 421.45, 1986.
11. Chaudhuri Swapna, Sinha A., Sengupta A. and Chaudhuri S.: Sheep erythrocyte provide metabolic triggers for tumour phagocytosis in polymorphonuclear neutrophil: a possible mechanism of tumour inhibition in mice. Biochem. Int. 23: 231-238, 1991.
12. Chaudhuri Swapna, Dutta S.K., Roy N., Gangopadhyay S.K., Chaudhuri S.: Immunomodulation and "Ia" variability in Dendritic lymph cells: A radiobinding immunoassay versus immuno response study. Biochem. and Mol. Biol. Int. 30: 471-477, 1993.
13. Chaudhuri S., Barfoot R., Denham S. and Hall J.G.: The stimulation by Dendritic cells of host versus graft reactivity in vivo. Immunol. and Cell Biol. 71: 527-533, 1993.
14. Siliciano R.F., Pratt J.C., Schmidt R.E., Ritz J., Reinlerz E.L.: Activation of cytolytic T-lymphocyte and natural killer cell function through the T-II sheep erythrocyte binding protein. Nature 317: 428-430, 1985.
15. Hunig T.R.: The ligand of the erythrocyte receptor of T-lymphocytes: Expression on white blood cells and possible involvement in T cell activation. J. Immunol. 136 (6): 2103-2108, 1986.
16. Druckrey H., Invancovic S., Preussmann R.: Teratogenic and carcinogenic effects in the offspring after single injection of ethylnitrosourea to pregnant rats. Nature 210: 1378-1379, 1966.
17. Koestener A., Swenberg J.A., Wechsler W.: Transplacental production with ethylnitrosourea of neoplasms of the nervous system in Sprague - Dawley rats. Am. J. Path. 63: 37-50, 1971.
18. Moore K.A. and Belmont J.W.: Gene Targeting. Oxford University Press, 1994, 63-69.
19. Kinchington D. and Ng T.: Separation and maintenance of primary T and B - lymphocytes. In: Pollard J.W. and Walker J.M., eds. Basic Cell culture protocols. Totowa, New Jersy: Humana Press 1997: 94-95.
20. Chaudhuri S., Maiti D., Law S., Palit A., Majumder D., Dattachaudhuri M. and Chaudhuri S.: Immunokinetics of ex-vivo expanded bone marrow cells: BRM treatment to leukaemic mice triggers greater immunopotentiation and protein tyrosine kinase (PTK) activity in expanded bone marrow cells. The Immunologist Suppl 1: 20, 1998.
21. Litchman M.A.: Cellular deformability during maturation of the myeloblast. New Eng. J. Med. 283: 943-945, 1970.
22. Litchman M.A., Chamberlain J.K., Weed R.I., Pincus A., Santillo P.A.: The regulation of the release of granulocytes from normal marrow. In: Green Walt T.J and Jamieson G.A. eds. The granulocyte function and clinical utilization. New York: Alan R Less. 1977: 53-63.
23. Botnick L.E., Hannon E.C., Hellman S.: Nature of the haemopoietic stem cell compartment and its proliferative potential. Blood Cells. 5: 195-200, 1979.
24. Cartwright G.E., Athens J.W., Wintrobe M.M.: The kinetics of Granulopoiesis in normal man. Blood 24: 780-783, 1964.
25. Metcalf D.: The Haemopoietic growth factors. Amsterdam, Netharland and Elseviers, 1984, 1.
26. Williams D.A., Rios M., Stephens C.: Fibronectin and VLA-4 in Haematopoietic stem cells. Nature 352: 438-443, 1991.
27. Hunig T.: The cell surface molecule recognized by the erythrocyte receptor of T-lymphocyte. J. Exp. Med. 162: 890-901, 1985.
28. Sarkar S., Begum Z., Dutta S., Dutta S.K., Chaudhuri, S. and Chaudhuri Swapna: Sheep form of Leucocyte Function Antigen - 3(TIITS) exerts immunostimulatory and Anti - tumour activity against experimental brain tumour. A new approach to Biological Response Modifier therapy. J. Exp. Clin. Cancer Res. 21: 609-620, 2002.
29. Sarkar S., Ghosh A., Mukherjee J., Bhattacharya M.K., Chaudhuri S. and Chaudhuri Swapna: Immunotherapy with Biological Response modifiers: An approach to brain tumour therapy. Bul. Inst. P. G. Med. Edu. & Res. XXIX, No. 1, 27-36, 2002.
30. Chaudhuri S., Sarkar S., Chaudhuri, S.: Malignant brain tumour. In: Singh A.K. ed. Indian Clinical Neurosurgery. Vol-II. New Delhi, India: CBS Publishers and Distributors, 2002: 280-306.